Cancer, Lipids, and Metabolism
Cancer, Lipids, and Metabolism is a research topic within Cancer Research. Science Explorer counts 43k research works in it since 1950. 18.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of lipid metabolism, including fatty acid synthesis, cholesterol metabolism, and statin use, in the pathogenesis and progression of cancer. It discusses the metabolic reprogramming of cancer cells, the impact of specific enzymes and receptors such as Fatty Acid Synthase and CD36, and the potential therapeutic implications of targeting lipid metabolism in cancer treatment.
- Lipid Metabolism
- Fatty Acid Synthase
- Cholesterol
- Statins
- Cancer
- Metabolic Reprogramming
- Lipogenesis
- CD36 Receptor
- HMG-CoA Reductase Inhibitors
- Acetyl-CoA Carboxylase
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 7.9k per year above
- Top-10% rate
- 18.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +19% the tick is no change
Which countries lead Cancer, Lipids, and Metabolism research?
By volume, China and the United States publish the most (3k and 1.5k works in 2022–2025).
By volume, 2022–2025
- 1 China 3k works
- 2 United States 1.5k works
- 3 India 320 works
- 4 Japan 275 works
- 5 Italy 259 works
- 6 South Korea 245 works
- 7 Germany 188 works
- 8 United Kingdom 184 works
- 9 France 141 works
- 10 Iran 135 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer, Lipids, and Metabolism research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Cancer, Lipids, and Metabolism research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Nanjing Medical University.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 51 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 48 works
- 3 Nanjing Medical UniversityChina 35 works
- 4 Central South UniversityChina 31 works
- 5 Sichuan UniversityChina 31 works
- 6 University of North Carolina at Chapel HillUnited States 31 works
- 7 The University of Texas MD Anderson Cancer CenterUnited States 30 works
- 8 Huazhong University of Science and TechnologyChina 30 works
- 9 Capital Medical UniversityChina 28 works
- 10 Zhejiang UniversityChina 28 works
Who are the leading researchers in Cancer, Lipids, and Metabolism?
The most-cited researchers publishing on Cancer, Lipids, and Metabolism include Walter C. Willett, Hermann Brenner and Amirhossein Sahebkar.
- 1 Walter C. Willett United States 6.8k citations
- 2 Hermann Brenner Germany 5.8k citations
- 3 Amirhossein Sahebkar Iran 5.6k citations
- 4 Valentı́n Fuster United States 5.4k citations
- 5 Josef Coresh United States 5.3k citations
- 6 Winfried März Germany 5.2k citations
- 7 Maciej Banach Poland 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cancer, Lipids, and Metabolism research done?
The largest centres of Cancer, Lipids, and Metabolism research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nantong.
Largest cities, 2022–2025
Where it is the local speciality
- NantongCN · 28.0 works7.6×
Location quotient: how much more of its research is in Cancer, Lipids, and Metabolism than the world average.
Where is the best place to study Cancer, Lipids, and Metabolism?
Among universities, judged by research, Shanghai University of Traditional Chinese Medicine, Zhejiang Chinese Medical University and China Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Shanghai University of Traditional Chinese MedicineChina | 62.1 | 42.9% | 10.4× | 16 | +32.2% |
| 2 | Zhejiang Chinese Medical UniversityChina | 61.9 | 36.0% | 9.8× | 20 | +70.0% |
| 3 | China Medical UniversityChina | 60.6 | 38.1% | 9.8× | 25 | -23.3% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 60.3 | 32.6% | 6.2× | 48 | +46.4% |
| 5 | Harbin Medical UniversityChina | 59.8 | 39.3% | 12.5× | 20 | -18.1% |
| 6 | Shanghai Medical College of Fudan UniversityChina | 59.8 | 46.4% | 14.7× | 9 | +31.4% |
| 7 | Nanjing Medical UniversityChina | 58.7 | 29.2% | 8.8× | 35 | +6.2% |
| 8 | Guangzhou Medical UniversityChina | 57.2 | 36.7% | 9.2× | 20 | -12.5% |
| 9 | Sun Yat-sen UniversityChina | 56.4 | 35.2% | 4.0× | 51 | +36.7% |
| 10 | Dalian Medical UniversityChina | 56.1 | 29.1% | 12.2× | 18 | +35.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cancer, Lipids, and Metabolism research growing?
Output in 2018–2022 was 19% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Cancer, Lipids, and Metabolism.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.